Patent · US Expired

5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors

US7396843B2 · kind B2 · utility

10Cited by
50References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2002
Grant dateJul 8, 2008
Priority date
Expiry dateDec 13, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.